Medtronic to buy Salient for $500M+
Medical device giant Medtronic said it will acquire Salient Surgical Technologies in Portsmouth, NH for $525 million. Established in 1999 and formerly known as Tissuelink Medical, Salient makes devices that stop bleeding and seal wounds by allowing surgeons to apply focused radio-frequency energy and saline solution to collagen fibers in the body. Given Medtronic’s previous ownership stake in Salient, the actual price tag will be $480 million. Previous investors in Salient include Piper Jafray Ventures, Arnerich Messina & Associates, and Rivervest Venture Partners.